ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS OF TREATING BLEPHARITIS Russian patent published in 2025 - IPC A61K9/08 A61K31/45 A61P27/02 A61P33/14 

Abstract RU 2840921 C2

FIELD: medicine; pharmaceutics.

SUBSTANCE: group of inventions relates to the pharmaceutical industry, specifically to the treatment of Demodex blepharitis in a human patient. Method of treating Demodex blepharitis in a human patient, comprising: local introduction directly on the ocular surface of one or more eyes of the patient in need of treatment, an effective amount of Lotilaner prepared in the ophthalmic composition, wherein said ophthalmic composition contains 0.25 wt.% of Lotilaner based on the total weight of said composition, wherein said ophthalmic composition is sterile, and wherein said Lotilaner is the only active ingredient of said ophthalmic composition. Method of treating Demodex blepharitis in a human patient, comprising: local administration directly to one or more of the eye, eyelids or eyelashes of a patient in need of treatment, an effective amount of Lotilaner prepared in an ophthalmic composition, wherein said ophthalmic composition contains 0.25 wt.% of Lotilaner based on the total weight of said composition, and said ophthalmic composition is sterile. Method of treating Demodex ocular invasion in a human patient, comprising: local administration directly to one or more eyes, eyelids or eyelashes of one or more eyes of a patient in need of treatment, an effective amount of Lotilaner prepared in an ophthalmic composition, wherein said ophthalmic composition contains 0.25 wt.% of Lotilaner based on the total weight of said composition, and said ophthalmic composition is sterile. Method of treating Demodex blepharitis in a human patient, comprising: topical application of Lotilaner, prepared as part of an ophthalmic composition, near one or more eyelashes, wherein said ophthalmic composition contains 0.25 wt.% of Lotilaner based on total weight of said composition, wherein said topical application is therapeutically effective for preferential absorption of Demodex mite body compared to ingestion by Demodex mite sufficient to cause a decrease in the movement of the body of the Demodex mite compared to the head of the Demodex mite, wherein said method is sufficient to reduce or eliminate Demodex mites near eyelashes, as a result of which there is relief of manifestations of blepharitis. Topical ophthalmic formulation for treating Demodex blepharitis in a human patient, comprising: effective amount of Lotilaner, prepared in ophthalmic composition, wherein said ophthalmic composition contains 0.25 wt.% of Lotilaner based on the total weight of said composition, wherein said ophthalmic composition is sterile, and wherein said Lotilaner is the only active ingredient of said ophthalmic formulation. Ophthalmic composition for treating Demodex blepharitis in a human patient, containing Lotilaner, wherein said ophthalmic composition is in the form of eye drops, wherein said ophthalmic composition is sterile, and Lotilaner is present in amount of 0.25 wt.% based on the total weight of said composition.

EFFECT: above-described group of inventions provides effective treatment of Demodex blepharitis in a human patient using a composition in the form of eye drops having high bioavailability.

19 cl, 4 dwg, 1 tbl

Similar patents RU2840921C2

Title Year Author Number
PREPARATION "DEMALAN-AKTIV" FOR DEMODECOSIS TREATMENT 2006
  • Petrenko Aleksandr Egorovich
  • Bagrov Sergej Nikolaevich
  • Ronkina Tamara Il'Inichna
  • Nemtsova Marina Viktorovna
  • Tigashova Irina Mikhajlovna
RU2313356C1
JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS 2013
  • Markov Il'Ja Aleksandrovich
  • Majchuk Jurij Fedorovich
  • Majchuk Dmitrij Jur'Evich
  • Markova Elena Alekseevna
  • Markova Inna Nikolaevna
  • Gaponjuk Polina Petrovna
  • Gaponjuk Petr Jakovlevich
RU2533274C1
DIAGNOSTIC TECHNIQUE FOR DEMODECTIC BLEPHARITIS 2024
  • Igonin Gleb Sergeevich
  • Svetozarskii Sergei Nikolaevich
  • Smetankin Igor Glebovich
RU2828003C1
GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT 2016
  • Markov Ilya Aleksandrovich
  • Majchuk Yurij Fedorovich
  • Majchuk Dmitrij Yurevich
  • Markova Elena Alekseevna
  • Gaponyuk Polina Petrovna
  • Markova Inna Nikolaevna
RU2633054C1
USE OF COMPOUNDS FOR CONTROL OR DESTRUCTION OF MITES 2021
  • Chzhan, Yan
RU2836883C1
PERSONAL HYGIENE AGENT WITH ACARICIDAL ACTIVITY ON MITE DEMODEX 2016
  • Medvedev Igor Borisovich
  • Bagrov Sergej Nikolaevich
  • Medvedeva Natalya Igorevna
  • Neshchadim Gennadij Nikolaevich
  • Dergacheva Nadezhda Nikolaevna
RU2611347C1
METHOD OF TREATING DEMODECTOSIS 2016
  • Medvedev Igor Borisovich
  • Bagrov Sergej Nikolaevich
  • Klyuvaeva Tatyana Yurevna
  • Medvedeva Natalya Igorevna
  • Neshchadim Gennadij Nikolaevich
  • Dergacheva Nadezhda Nikolaevna
  • Markosyan Armida Grishan
  • Evgrafov Vladimir Yurevich
  • Panchenko Aleksej Viktorovich
  • Kolesnikova Lidiya Nikolaevna
RU2611346C1
METHOD OF MAKING MIXTURE FOR GETTING RID OF ARTHROPODS 2024
  • Gordon Wayne Dyer
RU2838200C1
COMPOSITIONS AND USE THEREOF FOR TREATING OR PREVENTING ROSACEA 2017
  • Jacovella, Jean
  • Roye, Olivier
  • Jomard, Andre
RU2738932C2
METHOD FOR ESTIMATING ACARICIDE PREPARATIONS ACTIVITY IN TREATING THE CASES OF EYE DEMODICOSIS 2003
  • Aznabaev M.T.
  • Gumerova E.I.
  • Mal'Khanov V.B.
RU2249211C1

RU 2 840 921 C2

Authors

Khikok, Shon D.

Azamyan, Bobak Robert

Vekhidzh, Dzhozef G.

Akermann, Duglas Majkl

Dates

2025-05-30Published

2018-12-14Filed